Organ transplant recipients given mammalian target of rapamycin inhibitor (mTORi) have
reduced incidence of de novo posttransplant malignancies (dNPTMs). Posttransplant …

Background Kaposi's sarcoma (KS) is a vascular malignancy primarily involving the skin.
This neoplasm occurs commonly in acquired immunodeficiency syndrome (AIDS) and post …

Human herpesviruses (HHV) 6 and 7 are ubiquitous infections that reactivate commonly in
transplant recipients. However, clinical diseases due to these viruses are reported only in …

Background Infection with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) often
results in the development of fatal tumors in immunocompromised patients. Studies of renal …

Human herpesvirus 6 (HHV-6) and HHV-7 are lymphotropic β-herpesviruses that infect the
majority of humans during the first few years of life. Primary HHV-6 and HHV-7 infections …

Kaposi's sarcoma (KS) is an enigmatic vascular neoplasm that has reached epidemic
proportions in parts of the developing world and is a leading cause of morbidity and mortality …

Human herpesvirus (HHV)-6A, HHV-6B and HHV-7 are lymphotropic β-herpesviruses that
are almost universally acquired during the first few years of life and establish latency in …

In recent years, immunosuppression (IS) after liver transplantation (LT) has become
increasingly diversified as the choice of agents has expanded and clinicians seek to …

Dermatological complications following transplantation are very common and the majority of
immunosuppressed transplant recipients develop some to many warts due to human …

Malignancy is a significant cause of mortality after organ transplantation. There is an
increased rate of malignancy following heart transplantation (HTx) compared to the general …